IL90573A - Extraction and cleansing of anticoagulant substance from South American lizard - Google Patents

Extraction and cleansing of anticoagulant substance from South American lizard

Info

Publication number
IL90573A
IL90573A IL9057389A IL9057389A IL90573A IL 90573 A IL90573 A IL 90573A IL 9057389 A IL9057389 A IL 9057389A IL 9057389 A IL9057389 A IL 9057389A IL 90573 A IL90573 A IL 90573A
Authority
IL
Israel
Prior art keywords
factor
activity
anticoagulant
fxa
inhibiting
Prior art date
Application number
IL9057389A
Other languages
English (en)
Hebrew (he)
Other versions
IL90573A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL90573A0 publication Critical patent/IL90573A0/xx
Publication of IL90573A publication Critical patent/IL90573A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
IL9057389A 1988-06-16 1989-06-12 Extraction and cleansing of anticoagulant substance from South American lizard IL90573A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/207,415 US4832849A (en) 1988-06-16 1988-06-16 Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii

Publications (2)

Publication Number Publication Date
IL90573A0 IL90573A0 (en) 1990-01-18
IL90573A true IL90573A (en) 1994-07-31

Family

ID=22770459

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9057389A IL90573A (en) 1988-06-16 1989-06-12 Extraction and cleansing of anticoagulant substance from South American lizard

Country Status (22)

Country Link
US (1) US4832849A (zh)
EP (1) EP0346894B1 (zh)
JP (1) JPH02138300A (zh)
KR (1) KR910000171A (zh)
CN (1) CN1034335C (zh)
AR (1) AR244702A1 (zh)
AT (1) ATE118013T1 (zh)
AU (1) AU621124B2 (zh)
CA (1) CA1335666C (zh)
DE (1) DE68920915T2 (zh)
DK (1) DK295589A (zh)
ES (1) ES2070145T3 (zh)
FI (1) FI94487C (zh)
GR (1) GR3015946T3 (zh)
HU (1) HU205149B (zh)
IE (1) IE61363B1 (zh)
IL (1) IL90573A (zh)
NO (1) NO178717C (zh)
NZ (1) NZ229503A (zh)
PH (1) PH26374A (zh)
PT (1) PT90861B (zh)
ZA (1) ZA894394B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8501241B1 (en) 2012-09-17 2013-08-06 Biopep Solutions, Inc. Treating cancer with a whole, leech saliva extract

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385885A (en) * 1988-01-15 1995-01-31 Gasic; Gregory P. Inhibition of smooth muscle cell proliferation by antistasin and tick anticoagulant peptide
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
IL86856A0 (en) * 1988-06-24 1988-11-30 Yissum Res Dev Co Bovine xa factor and pharmaceutical compositions containing the same
US5120537A (en) * 1989-06-14 1992-06-09 Oklahoma Medical Research Foundation Factor xa based anticoagulant compositions
KR0185973B1 (ko) * 1989-06-20 1999-05-01 게리 디. 스트리트 남미의 거머리인 헤멘테리아 길리아니로부터의 항전이 물질 길란텐
US5239058A (en) * 1989-09-07 1993-08-24 Merck & Co., Inc. Proteins having anticoagulant properties
US5328997A (en) * 1989-09-07 1994-07-12 Merck & Co., Inc. Processes for making proteins having anticoagulant properties
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
DE4001238A1 (de) * 1990-01-18 1991-07-25 Basf Ag Verfahren zur anreicherung bzw. reinigung von biomolekuelen
DE69122280T2 (de) * 1990-03-01 1997-04-24 Hewlett Packard Co Minimierung von Eluatbandbreiten in der Flüssigchromatographie
GB9007879D0 (en) * 1990-04-06 1990-06-06 Biopharm Ltd Treatment of thrombotic events
US5189019A (en) * 1990-04-23 1993-02-23 Merck & Co., Inc. Antistasin derived anticoagulant protein
CA2047527A1 (en) * 1990-07-24 1992-01-25 Christopher Dunwiddie Method for administering a therapeutic anticoagulant
CA2052486A1 (en) * 1990-10-09 1992-04-10 Thomas M. Connolly Protein for inhibiting collagen-stimulated platelet aggregation
GB9022040D0 (en) * 1990-10-10 1990-11-21 Biopharm Ltd Platelet adhesion inhibitor
DE4234921A1 (de) * 1992-10-16 1994-04-21 Basf Ag Neues, die Gerinnungszeit des Blutes verlängerndes Protein aus dem Landblutegel Haemadipsa sylestris
ATE213155T1 (de) * 1993-04-09 2002-02-15 Bio Technology General Corp Herstellung eines rekombinanten inhibitors des faktors xa des blutegels hirudo medicinalis
US5783421A (en) 1993-04-09 1998-07-21 Bio-Technology General Corp. DNA encoding novel polypeptide having Factor Xa inhibitory activity
DK0696198T3 (da) * 1993-04-09 2001-08-06 Bio Technology General Corp Nyt polypeptid, der har inhiberende virkning mod faktor Xa
US7005510B1 (en) * 1993-06-23 2006-02-28 Beckman Instruments, Inc. Recombinant DNase B derived from Streptococcus pyogenes
CN1057911C (zh) * 1994-08-30 2000-11-01 中国人民解放军264医院 治疗心血管病的中药及其制作方法
KR0141651B1 (ko) * 1994-09-07 1998-06-15 강재헌 금속이온 친화성 크로마토그라피를 이용한 히루딘의 정제방법
CN1089006C (zh) * 1999-08-13 2002-08-14 中国科学院生态环境研究中心 一种从茶叶提取活化的凝血因子十抑制组分（ati）方法
US7927612B2 (en) * 2000-01-19 2011-04-19 Baofa Yu Combinations and methods for treating neoplasms
CN100405060C (zh) * 2006-01-24 2008-07-23 李振国 一种水蛭指纹图谱的建立方法和水蛭药材的鉴别方法
CN101138634A (zh) 2006-09-07 2008-03-12 于保法 用于治疗肿瘤的组合物
CN101412726B (zh) * 2007-10-15 2011-05-11 南京中医药大学 杂环类化合物
US20100317827A1 (en) * 2008-02-06 2010-12-16 Biocon Limited Method of Purifying a Peptide
KR101341289B1 (ko) * 2013-07-09 2013-12-12 한선대 거머리 타액의 채취방법
CN107106531A (zh) 2014-11-26 2017-08-29 于保法 微创精准个体化肿瘤内化学诱导免疫治疗方法半抗原增强的化学免疫治疗
CN105349601A (zh) * 2015-11-17 2016-02-24 常熟理工学院 一种具有抗菌活性的水蛭多肽锌螯合物的制备方法
CN105890960A (zh) * 2016-05-06 2016-08-24 同济大学 一种蛋白质预分离方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3300383A (en) * 1963-10-15 1967-01-24 Dresden Arzneimittel Hirudine from leeches and process for recovery thereof
US3432596A (en) * 1967-10-13 1969-03-11 Dresden Arzneimittel Method for producing highly pure hirudine
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent
US4588587A (en) * 1983-03-01 1986-05-13 Pennsylvania Hospital Method of treatment to inhibit metastasis
NO170430C (no) * 1986-09-18 1992-10-14 Pennsylvania Hospital Fremgangsmaate for fremstilling av et protein som har antikoagulerende og anti-metastatiske egenskaper

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8501241B1 (en) 2012-09-17 2013-08-06 Biopep Solutions, Inc. Treating cancer with a whole, leech saliva extract
US8685462B1 (en) 2012-09-17 2014-04-01 Biopep Solutions, Inc. Whole, leech saliva product and applications thereof
US8784896B2 (en) 2012-09-17 2014-07-22 Biopep Solutions, Inc Antioxidant therapy with a whole, leech saliva extract
US8790711B2 (en) 2012-09-17 2014-07-29 Biopep Solutions, Inc. Treating diabetes with a whole, leech saliva extract
US8962034B2 (en) 2012-09-17 2015-02-24 Biopep Solutions, Inc. Antiviral therapy with a whole, leech saliva extract
US9017732B1 (en) 2012-09-17 2015-04-28 Biopep Solutions, Inc. Antibacterial therapy with a whole, leech saliva extract
US9149498B2 (en) 2012-09-17 2015-10-06 Biopep Solutions, Inc. Treating a parasitic disease with a whole, leech saliva extract
US9265802B2 (en) 2012-09-17 2016-02-23 Biopep Solutions, Inc. Treating colorectal cancer with a whole, leech saliva extract
US9265803B2 (en) 2012-09-17 2016-02-23 Biopep Solutions, Inc. Treating a melanoma with a whole, leech saliva extract
US9433649B2 (en) 2012-09-17 2016-09-06 Biopep Solutions, Inc. Treating a lymphoma with a whole, leech saliva extract
US9433648B2 (en) 2012-09-17 2016-09-06 Biopep Solutions, Inc. Treating renal cancer with a whole, leech saliva extract
US9480720B1 (en) 2012-09-17 2016-11-01 Biopep Solutions, Inc. Treating damaged dermal or mucosal tissue with a whole, leech saliva extract
US9597361B2 (en) 2012-09-17 2017-03-21 Biopep Solutions, Inc. Treating a bacterial skin infection with a whole, leech saliva extract

Also Published As

Publication number Publication date
DE68920915T2 (de) 1995-05-24
HUT50197A (en) 1989-12-28
US4832849A (en) 1989-05-23
CN1038649A (zh) 1990-01-10
ATE118013T1 (de) 1995-02-15
AR244702A1 (es) 1993-11-30
NO892498L (no) 1989-12-18
DE68920915D1 (de) 1995-03-16
NO178717C (no) 1996-05-22
EP0346894B1 (en) 1995-02-01
IE891941L (en) 1989-12-16
FI892947A (fi) 1989-12-17
ES2070145T3 (es) 1995-06-01
KR910000171A (ko) 1991-01-29
PT90861B (pt) 1994-11-30
DK295589D0 (da) 1989-06-15
JPH02138300A (ja) 1990-05-28
DK295589A (da) 1989-12-17
EP0346894A3 (en) 1990-04-25
CA1335666C (en) 1995-05-23
IL90573A0 (en) 1990-01-18
CN1034335C (zh) 1997-03-26
ZA894394B (en) 1990-02-28
NO178717B (no) 1996-02-12
IE61363B1 (en) 1994-11-02
FI94487B (fi) 1995-06-15
FI94487C (fi) 1995-09-25
PT90861A (pt) 1989-12-29
NO892498D0 (no) 1989-06-15
AU621124B2 (en) 1992-03-05
EP0346894A2 (en) 1989-12-20
GR3015946T3 (en) 1995-07-31
AU3634389A (en) 1989-12-21
PH26374A (en) 1992-06-01
HU205149B (en) 1992-03-30
NZ229503A (en) 1991-09-25
FI892947A0 (fi) 1989-06-15

Similar Documents

Publication Publication Date Title
CA1335666C (en) Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii
Electricwala et al. Isolation of thrombin inhibitor from the leech Hirudinaria manillensis
Condra et al. Isolation and Structural Charaderization of a Potent Inhibitor of Coagulation Factor Xa from the Leech Haementeria ghilianii
Siigur et al. Biochemical characterization of lebetase, a direct-acting fibrinolytic enzyme from Vipera lebetina snake venom
US5472942A (en) Anti-thrombins
EP0263608A2 (en) Protein having anticoagulant and antimetastatic properties
US6025330A (en) Inhibitors of fibrin cross-linking and/or transglutaminases
US5447911A (en) Ghilanten antimetastatic principle from the south american leech, Haementeria ghilianii
US5583111A (en) Thrombin inhibitors
Braun et al. Preparation and characterization of proteolyzed forms of human α-thrombin
Brankamp et al. Studies on the anticoagulant, antimetastatic and heparin-binding properties of ghilanten-related inhibitors
US5977056A (en) Treatment of thrombotic events
SOEDA et al. An inhibitor of proline endopeptidase: purification from rat brain and characterization
RU2112528C1 (ru) СПОСОБ ПОЛУЧЕНИЯ ФЕРМЕНТА ДЕСТАБИЛАЗЫ, ОБЛАДАЮЩЕГО ФИБРИНОЛИТИЧЕСКОЙ, ТРОМБОЛИТИЧЕСКОЙ, ЭНДО- И ЭКЗО- ε(γ GLY)-LYS-ИЗОПЕПТИДАЗНОЙ И АМИДОЛИТИЧЕСКОЙ АКТИВНОСТЬЮ
US4487718A (en) Peptides
CA2058635C (en) Treatment of thrombotic events
Asghar et al. Human plasma kallikreins and their inhibition by amidino compounds
SILVA E. HABERMANN

Legal Events

Date Code Title Description
RH Patent void
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.